Ocuphire Pharma (OCUP) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Ocuphire Pharma, Inc. has appointed Nirav Jhaveri as its new Chief Financial Officer, bringing with him an extensive background from his previous CFO role at Insilico Medicine and experience in biopharmaceuticals and finance. To attract a professional of Jhaveri’s caliber, the company has structured a compelling compensation package, including a $410,000 base salary, stock options, and restricted stock awards with specific vesting schedules, along with the potential for a sizable bonus and severance benefits under certain conditions. This strategic hire aims to strengthen Ocuphire Pharma’s financial leadership as they move forward in the competitive biotech industry.
For further insights into OCUP stock, check out TipRanks’ Stock Analysis page.
